Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells.

cell cycle mesenchymal stem cell resveralogue resveratrol

Journal

Journal of equine science
ISSN: 1340-3516
Titre abrégé: J Equine Sci
Pays: Japan
ID NLM: 9503751

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 04 01 2023
accepted: 28 04 2023
medline: 2 10 2023
pubmed: 2 10 2023
entrez: 2 10 2023
Statut: ppublish

Résumé

Resveratrol (RSV; trans-3,5,4'-trihydroxystilbene) strongly activates sirtuin 1, and it and its analogue V29 enhance the proliferation of mesenchymal stem/stromal cells (MSCs).Although culture medium containing 5-azacytydine and RSV inhibits senescence of adipose tissue-derived MSCs isolated from horses with metabolic syndrome, few studies have reported the effects of RSV on equine bone marrow-derived MSCs (eBMMSCs) isolated from horses without metabolic syndrome. The aim of this study was to investigate the effects of RSV and V29 on the cell cycle of eBMMSCs. Following treatment with 5 µM RSV or 10 µM V29, the cell proliferation capacity of eBMMSCs derived from seven horses was evaluated by EdU (5-ethynyl-2'-deoxyuridine) and Ki-67 antibody assays. Brightfield images of cells and immunofluorescent images of EdU, Ki-67, and DAPI staining were recorded by fluorescence microscopy, and the number of cells positive for each was quantified and compared by Friedman's test at P<0.05. The growth fraction of eBMMSCs was significantly increased by RSV and V29 as measured by the EdU assay (control 28.1% ± 13.8%, V29 31.8% ± 14.6%, RSV 32.0% ± 10.8%; mean ± SD; P<0.05) but not as measured by the Ki-67 antibody assay (control 27.0% ± 11.2%, V29 27.4% ± 10.8%, RSV 27.7% ± 6.8%). RSV and V29 promoted progression of the cell cycle of eBMMSCs into the S phase and may be useful for eBMMSC expansion.

Identifiants

pubmed: 37781569
doi: 10.1294/jes.34.67
pii: 2301
pmc: PMC10534064
doi:

Types de publication

Journal Article

Langues

eng

Pagination

67-72

Informations de copyright

©2023 The Japanese Society of Equine Science.

Références

J Cell Physiol. 2019 Jul;234(7):10942-10963
pubmed: 30537190
Equine Vet J. 2012 Sep;44(5):587-93
pubmed: 22150794
Trends Biotechnol. 2007 Sep;25(9):409-16
pubmed: 17692415
Biogerontology. 2020 Dec;21(6):817-826
pubmed: 32793997
Stem Cells Int. 2019 Jul 24;2019:7513404
pubmed: 31428160
Sci Rep. 2019 Feb 4;9(1):1296
pubmed: 30718685
Mol Cells. 2016 May 31;39(5):418-25
pubmed: 27109421
Animals (Basel). 2021 Jan 19;11(1):
pubmed: 33477808
Curr Drug Metab. 2014 Jan;15(1):77-95
pubmed: 24329110
Curr Protoc Mol Biol. 2015 Jul 01;111:28.6.1-28.6.11
pubmed: 26131851
J Tissue Eng Regen Med. 2018 Feb;12(2):e1008-e1021
pubmed: 28107614
Toxicol In Vitro. 2006 Sep;20(6):915-22
pubmed: 16524694
J Neurosci Methods. 2009 Feb 15;177(1):122-30
pubmed: 18996411
J Mol Med (Berl). 2012 Apr;90(4):389-400
pubmed: 22038097
BMC Cell Biol. 2017 Oct 17;18(1):31
pubmed: 29041897
Oxid Med Cell Longev. 2019 May 12;2019:1523140
pubmed: 31214275
Int J Mol Sci. 2019 Jan 28;20(3):
pubmed: 30695995
Phytomedicine. 2007 Dec;14(12):806-14
pubmed: 17689939
Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):431-7
pubmed: 19474719
J Orthop Res. 2009 Dec;27(12):1675-80
pubmed: 19544397
Pharmazie. 2015 Dec;70(12):765-71
pubmed: 26817272
Nutr Res Rev. 2018 Jun;31(1):85-97
pubmed: 29191255
Vet Rec Open. 2021 Nov 10;8(1):e22
pubmed: 34795904
Curr Biol. 2006 Feb 7;16(3):296-300
pubmed: 16461283
Biochem Biophys Res Commun. 2015 Nov 27;467(4):1026-32
pubmed: 26456654
PLoS One. 2013 Sep 25;8(9):e75697
pubmed: 24086616
J Exp Clin Cancer Res. 2016 Jul 22;35(1):118
pubmed: 27448598
Life (Basel). 2022 Mar 16;12(3):
pubmed: 35330187
Annu Rev Pharmacol Toxicol. 2014;54:363-80
pubmed: 24160699
J Equine Vet Sci. 2019 Jan;72:16-27
pubmed: 30929778
Vet Q. 2014;34(2):92-7
pubmed: 25072527
Nature. 2005 Mar 3;434(7029):113-8
pubmed: 15744310
J Cell Mol Med. 2018 Oct;22(10):4771-4793
pubmed: 29999247
Sci Rep. 2019 Nov 11;9(1):16527
pubmed: 31712718
Int J Mol Sci. 2019 Mar 19;20(6):
pubmed: 30893846
PLoS One. 2012;7(5):e37162
pubmed: 22615926
J Cell Mol Med. 2019 Jan;23(1):237-259
pubmed: 30370650
Stem Cell Res Ther. 2019 Oct 17;10(1):307
pubmed: 31623691
Int J Mol Sci. 2017 Oct 11;18(10):
pubmed: 29019941
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834

Auteurs

Norihisa Tamura (N)

Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Department of Clinical Sciences and Services, Royal Veterinary College, University of London, Hatfield AL9 7TA, UK.

Neda Heidari (N)

Department of Clinical Sciences and Services, Royal Veterinary College, University of London, Hatfield AL9 7TA, UK.

Richard G A Faragher (RGA)

School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK.

Roger K W Smith (RKW)

Department of Clinical Sciences and Services, Royal Veterinary College, University of London, Hatfield AL9 7TA, UK.

Jayesh Dudhia (J)

Department of Clinical Sciences and Services, Royal Veterinary College, University of London, Hatfield AL9 7TA, UK.

Classifications MeSH